The fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government plans. This book will bridge the gap. We will explore developments in both U.S. and International setting. The system of the U.S. is characterized by a mix of private and government insurance for prescription drugs with the expansion of Medicare Part D. Most other developed countries are characterized by social insurance with either the government as a single payer such as in Canada or Australia, or a national health service as in many other European countries.     Read more...      Part I: International reviews -- Pharmaceutical policies in European countries / Pedro Pita Barros -- International experience with comparative effectiveness research : case studies from England/Wales and Germany / John F.P. Bridges ... [et al.] -- Part II: National case studies -- Pharmaceutical policy in the Netherlands : from price regulation towards managed competition / Lieke H.H.M. Boonen ... [et al.] -- Impact of pharmaceutical regulation and policies on health system performance goals in israel / Philip Sax and Amir Shmueli -- Global budgets and provider incentives : hospitals' drug expenditures in Taiwan / Shin-Yi Chou ... [et al.] -- Medicare Part D turns four : trends in plan design, enrollment, and the impact of the program on beneficiaries / Jack Hoadley and Kosali Simon -- Part III: U.S. studies : from markets to policy innovations -- Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes / William E. Encinosa, Didem Bernard and Avi Dor -- Cost shring, benefit design, and adherence : the case of multiple sclerosis / Avi Dor ... [et al.] -- Generic utilization and cost-sharing for prescription drugs / Teresa Bernard Gibson, Catherine G. McLaughlin and Dean G. Smith -- Drug prices, out-of-pocket payments, and insurer costs : how do payers vary? / Jie Chen and John A. Rizzo -- Adverse selection and the effect of health insurance on utilization of prescribed medicine among patients with chronic conditions / Yuriy Pylypchuk -- The effect of drug vintage on survival : micro evidence from Puerto Rico's Medicaid program / Frank R. Lichtenberg -- Part IV: Special topics -- Retail pharmacy market structure and insurer-independent pharmacy bargaining in the Medicare Part D era / Yang Xie ... [et al.] -- Patents, innovation, and the welfare effects of Medicare Part D / Adam Gailey, Darius Lakdawalla and Neeraj Sood

Pharmaceutical Markets and Insurance Worldwide (Advances in Health Economics and Health Services Research) PDF

The list of books you might like